跳至主要内容
临床试验/IRCT2017010931062N2
IRCT2017010931062N2已完成2 期

Compare the complementary effect of radiofrequency ablation technique besides chemotherapy in patients with metastatic liver tumors from breast and control group under chemotherapy

Research department, Mazandaran University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
Female

入选标准

  • liver metastatic lesion from breast tissue verified by pathology; liver metastatic lesion far from intrahepatic bile ducts; liver metastatic lesion far from great veins more than 3 cm
  • Exclusion criteria: Acute febrile infection; Cr>2; Ascites; hepatic encephalopathy; INR>1.5; Bill>3; verified extrahepatic metastases; surgery candidates

排除标准

  • 未提供

研究者

发起方
Research department, Mazandaran University of Medical Sciences

相似试验